ICRF-187 - REDUCTION OF CHRONIC DAUNORUBICIN AND DOXORUBICIN CARDIOTOXICITY IN RABBITS, BEAGLE DOGS AND MINIATURE PIGS

被引：0

作者：

HERMAN, EH ^{[1
]}

FERRANS, VJ ^{[1
]}

机构：

[1] NHLBI,PATHOL BRANCH,BETHESDA,MD 20205

来源：

DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 1983年 / 9卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：483 / 490

页数：8

共 32 条

[21] Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines
E. H. Herman
J. Zhang
B. B. Hasinoff
D. P. Chadwick
J. R. Clark Jr.
V. J. Ferrans
Cancer Chemotherapy and Pharmacology, 1997, 40 : 400 - 408
[22] REDUCTION OF DAUNORUBICIN LETHALITY AND MYOCARDIAL CELLULAR ALTERATIONS BY PRETREATMENT WITH ICRF-187 IN SYRIAN GOLDEN-HAMSTERS
HERMAN, E
ARDALAN, B
BIER, C
WARAVDEKAR, V
KROP, S
CANCER TREATMENT REPORTS, 1979, 63 (01): : 89 - 92
[23] COMPARATIVE-STUDY OF DOXORUBICIN, MITOXANTRONE, AND EPIRUBICIN IN COMBINATION WITH ICRF-187 (ADR-529) IN A CHRONIC CARDIOTOXICITY ANIMAL-MODEL
ALDERTON, PM
GROSS, J
GREEN, MD
CANCER RESEARCH, 1992, 52 (01) : 194 - 201
[24] AMELIORATION OF DOXORUBICIN CARDIOTOXICITY BY THE BISPIPERAZINEDIONE ICRF-187 IN WOMEN WITH ADVANCED BREAST-CANCER - A PRELIMINARY-REPORT
JURGA, L
MISUROVA, E
VANCIK, J
NEOPLASMA, 1993, 40 (04) : 259 - 262
[25] The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells
Hasinoff, BB
Yalowich, JC
Ling, YZ
Buss, JL
ANTI-CANCER DRUGS, 1996, 7 (05) : 558 - 567
[26] TOXICITY PROFILE OF DEXRAZOXANE (ZINECARDR, ICRF-187, ADR-529, NSC-169780), A MODULATOR OF DOXORUBICIN CARDIOTOXICITY
CURRAN, CF
NARANG, PK
REYNOLDS, RD
CANCER TREATMENT REVIEWS, 1991, 18 (04) : 241 - 252
[27] COMPARISON OF THE CARDIOPROTECTIVE EFFECT OF DEFEROXAMINE (DFO) AND ICRF-187 ON CHRONIC DOXORUBICIN (DXR) CARDIOMYOPATHY IN SPONTANEOUSLY HYPERTENSIVE RATS (SHR)
HERMAN, EH
ZHANG, J
CHADWICK, DP
FERRANS, VJ
FASEB JOURNAL, 1994, 8 (05): : A885 - A885
[28] COMPARISON OF THE EFFECTIVENESS OF (+/-)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187) AND N-ACETYLCYSTEINE IN PREVENTING CHRONIC DOXORUBICIN CARDIOTOXICITY IN BEAGLES
HERMAN, EH
FERRANS, VJ
MYERS, CE
VANVLEET, JF
CANCER RESEARCH, 1985, 45 (01) : 276 - 281
[29] CARDIOPROTECTION WITH ICRF-187 (CARDIOXANE) IN PATIENTS WITH ADVANCED BREAST-CANCER HAVING CARDIAC RISK-FACTORS FOR DOXORUBICIN CARDIOTOXICITY, TREATED WITH THE FDC REGIMEN
JELIC, S
RADULOVIC, S
NESKOVICKONSTANTINOVIC, Z
KREACIC, M
RISTOVIC, Z
BOSNJAK, S
MILANOVIC, N
VULETIC, L
SUPPORTIVE CARE IN CANCER, 1995, 3 (03) : 176 - 182
[30] Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes
Working, PK
Newman, MS
Sullivan, T
Yarrington, J
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (02): : 1128 - 1133

← 1 2 3 4 →